SCHEMBL6318638

SCHEMBL6318638

COc1ccc(OC(=O)NCc2cc(C(=O)O)c(NC(=O)C(=O)O)s2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.50
RAB9A P51151 3/20 0.50
NPC1 O15118 2/20 0.50
PTPN1 P18031 1/20 0.44
ALDH1A1 P00352 6/20 0.43
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
KDM4E B2RXH2 4/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
POLB P06746 1/20 0.43
NPSR1 Q6W5P4 2/20 0.43
GAA P10253 4/20 0.42
TAAR1 Q96RJ0 1/20 0.42
HTT P42858 2/20 0.40
GFER P55789 1/20 0.40
TP53 P04637 1/20 0.40
PTPN2 P17706 1/20 0.39
PTPRB P23467 1/20 0.39
PTPN6 P29350 1/20 0.39
CHEK1 O14757 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6318762 0.90 HSD17B10 (0.45) MAPTRAB9ANPC1PTPN1ALDH1A1
SCHEMBL6318548 0.89 FAAH (0.41) MAPTRAB9ANPC1PTPN1ALDH1A1
SCHEMBL6313183 0.89 MGLL (0.42) MAPTRAB9ANPC1PTPN1ALDH1A1
SCHEMBL6318495 0.86 ALDH1A1 (0.44) MAPTRAB9ANPC1PTPN1ALDH1A1
SCHEMBL6312273 0.85 MGLL (0.46) MAPTRAB9ANPC1PTPN1ALDH1A1
SCHEMBL6316825 0.80 HSD17B10 (0.48) MAPTRAB9ANPC1ALDH1A1MEN1
SCHEMBL6312575 0.79 ALDH1A1 (0.41) MAPTRAB9ANPC1ALDH1A1MEN1
SCHEMBL6311917 0.79 SMN1; SMN2 (0.53) MAPTRAB9ANPC1ALDH1A1MEN1
SCHEMBL6311619 0.78 HSD17B10 (0.41) MAPTRAB9ANPC1ALDH1A1MEN1
SCHEMBL7516389 0.77 ALDH1A1 (0.40) MAPTRAB9ANPC1ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020165398-A1 Modulators of protein tyrosine phosphatases (PTPases) JEPPESEN LONE (DK) 2002-11-07 US claimed
US-20020002199-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 2002-01-03 US claimed
EP-1062204-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 2000-12-27 EP claimed
WO-1999046244-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 1999-09-16 WO claimed
US-20050119332-A1 Substituted thiophene compounds as modulators of protein tyrosine phosphatases (PTPases) JEPPESEN LONE (DK) 2005-06-02 US disclosed
US-20020165398-A1 Modulators of protein tyrosine phosphatases (PTPases) JEPPESEN LONE (DK) 2002-11-07 US disclosed
US-20020002199-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 2002-01-03 US disclosed
EP-1062204-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 2000-12-27 EP disclosed
WO-1999046244-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 1999-09-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020165398-A1 Modulators of protein tyrosine phosphatases (PTPases) PTPRCAP, PTPRS, PTPRO MAPT 540/4885RAB9A 2766/4885NPC1 3287/4885
US-20020002199-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) PTPRCAP, PTPRS, PTPRA MAPT 475/4885RAB9A 2751/4885NPC1 3245/4885
US-20050119332-A1 Substituted thiophene compounds as modulators of protein tyrosine phosphatases (PTPases) PTPRCAP, PTPRS, PTPN1 MAPT 626/4885RAB9A 2114/4885NPC1 2766/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.